Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aflibercept ophthalmic use Phase 4 study in Japan
jRCT1080222679Phase 4Completed
- Start
- Dec 2014
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4 trial of aflibercept in well-being. Started Dec 2014; status: completed.
02
Drugs
aflibercept
03
Conditions
well-being
Beyond the preview
Go deeper on jRCT1080222679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222679.